Jan Styczynski, Krzysztof Czyzewski, Ewa Demidowicz, Magdalena Wozniak, Marcin Plonowski, Malgorzata Sawicka-Zukowska, Ewa Bien, Ninela Irga-Jaworska, Tomasz Ociepa, Aleksandra Krolak, Tomasz Urasinski, Lukasz Hutnik, Anna Szmydki-Baran, Aleksandra Minkowska, Katarzyna Pikora, Paweł Laguna, Malgorzata Salamonowicz-Bodzioch, Jowita Fraczkiewicz, Krzysztof Kalwak, Katarzyna Derwich, Olga Zajac-Spychala
{"title":"Isavuconazole in treatment of invasive fungal disease in children with malignancy or undergoing cellular therapy.","authors":"Jan Styczynski, Krzysztof Czyzewski, Ewa Demidowicz, Magdalena Wozniak, Marcin Plonowski, Malgorzata Sawicka-Zukowska, Ewa Bien, Ninela Irga-Jaworska, Tomasz Ociepa, Aleksandra Krolak, Tomasz Urasinski, Lukasz Hutnik, Anna Szmydki-Baran, Aleksandra Minkowska, Katarzyna Pikora, Paweł Laguna, Malgorzata Salamonowicz-Bodzioch, Jowita Fraczkiewicz, Krzysztof Kalwak, Katarzyna Derwich, Olga Zajac-Spychala","doi":"10.1080/10428194.2024.2416021","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":" ","pages":"333-336"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2024.2416021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor